Large-Cell Lymphoma, Diffuse Withdrawn Phase 1 / 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0053962 (Large-Cell Lymphoma, Diffuse)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01415765MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaTreatment